A Study to Evaluate the Efficacy and Safety of Itolizumab in Subjects Hospitalized With COVID-19 (EQUINOX)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04605926 |
|
Recruitment Status :
Withdrawn
(Sponsor has currently elected to withhold study initiation)
First Posted : October 28, 2020
Last Update Posted : January 27, 2021
|
Sponsor:
Equillium
Collaborator:
Biocon Limited
Information provided by (Responsible Party):
Equillium
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
| Recruitment Status : | Withdrawn |
|---|---|
| Estimated Primary Completion Date : | April 2021 |
| Estimated Study Completion Date : | June 2021 |